Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EU CHMP Opinions and MAA Updates

Oct 19 2022

• By Neena Brizmohun

Related Content

ERC Not Giving Up On Glioma Immunotherapy In EU

May 23 2022

PTC’s ‘Life-Changing’ Gene Therapy Among Nine Drugs To Win EU Thumbs Up

May 20 2022

Kite Wins EMA Recommendation To Market Tecartus For Leukemia Patients

Jul 25 2022

Janssen’s Multiple Myeloma Drug Among 11 Products To Get EMA Thumbs Up

Jul 22 2022

Ophthalmic Bevacizumab Sponsor Not Giving Up On EMA Rejection

Jan 28 2022

BMS’ Cell Therapy For Lymphoma On Track For EU-Wide Approval

Jan 28 2022

EMA OKs First Drug To Prevent RSV Infection In Babies

Sep 16 2022

EMA Thumbs Up For Idorsia’s Insomnia Drug And Immunocore’s Uveal Melanoma Treatment

Feb 25 2022

EMA Gives Oncopeptides’ Multiple Myeloma Drug The Thumbs Up; Keeps US FDA In Loop

Jun 24 2022

BioMarin’s Hemophilia Gene Therapy Among Nine Products On Track For EU-Wide Approval

Jun 24 2022

Valneva Wins EU Nod For COVID-19 Vaccine

Jun 23 2022

Janssen’s Multiple Myeloma Gene Therapy On Track For EU-Wide Approval

Mar 25 2022

Marketing Firsts Due As Amryt’s Filsuvez And Roche’s Lunsumio Win EU Nod

Apr 25 2022

Biogen Pulls EU Filing For Aduhelm But Stands By Alzheimer’s Drug

Apr 22 2022

Dengue Vaccine Qdenga & Nine Drugs Win EMA Thumbs Up

Oct 17 2022

Additional Topics

Europe Drug Review Regulation Approvals Review Pathway BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window